Meet the 2017 Laureates: Matthias Tschöp, MD


Outstanding Innovation Award

Matthias Tschöp, MD


It was with great pleasure that I nominated physician-scientist Matthias Tschöp, MD, for the 2017 Outstanding Innovation Award of the Endocrine Society.

Professor Tschöp, who currently serves as director of the Helmholtz Diabetes Center and Chair of Metabolic Diseases at the Technische Universität München, Germany, discovered several leading classes of novel drug candidates in the field of diabetes, obesity, and metabolic diseases. His innovative and reproducible basic science work has led to development of multiple distinct novel investigational therapeutic agents now being assessed in clinical trials.

As a postdoctoral fellow, Dr. Tschöp reported on the orexigenic, adipogenic, and metabolic effects of ghrelin (Nature, 2000, >3500 citations). This groundbreaking discovery added a fundamental pathway to the model of body weight and glucose control, and established a novel set of drug targets (Nature Medicine, 2009; Science, 2010). He also was the first to report that ghrelin levels are regulated by both food intake and body weight (Diabetes, 2001; J Endocrinol Invest, 2001). He went on to collaborate with the chemist Richard DiMarchi to co-discover a paradigm shifting series of gut hormone-derived unimolecular poly-agonists that target several neuroendocrine receptors, reduce body weight and improve glucose tolerance with unprecedented efficacy (Nature Chemical Biology, 2009; Science Translational Medicine, 2013, Nature Medicine, 2015).

Dr. Tschöp’s innovative breakthroughs also encompass novel strategies for tissue-specific delivery of small molecules using peptide shuttles thereby more efficiently targeting pathological processes while minimizing toxic effects (Nature Medicine, 2012; Cell, 2016). In addition to more than 300 peer-reviewed publications, and numerous scientific awards (including Outstanding Scientific Achievement Awards of The Obesity Society 2009 and the American Diabetes Society 2011), Dr. Tschöp is an excellent collaborative colleague.

You may also like

  • Two European Universities Honor Leonard Wartofsky

    In June, Endocrine Society past-president Leonard Wartofsky, MD, MACP, professor of medicine at Georgetown University and editor-in-chief of Endocrine Reviews, was awarded doctorate honoris causa from both the University of Poznan in Poland and the University of Athens in Greece. “I think it’s a tremendous honor,” Wartofsky says. “It’s not something you really expect in…

  • Endocrine News Editor Talks Twitter in NYC

    Endocrine News editor Mark A. Newman spoke to members of the New York Society of Association Executives (NYSAE) in New York City on September 7 about how effectively the magazine has used Twitter over the last few years. Held at the headquarters of the American Heart Association in the historic Chanin Building, Newman was asked…

Find more in